Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.

Anita R PeoplesPeter W BushunowSheila N GarlandCharles E HecklerJoseph A RoscoeLuke L PepponeDeborah J DudgeonJeffrey J KirshnerTarit K BanerjeeJudith O HopkinsShaker R DakhilMarie A FlanneryGary R Morrow

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2015)

Buspirone did not result in significant improvement in dyspnea or anxiety in cancer patients. Thus, buspirone should not be recommended as a pharmacological option for dyspnea in cancer patients.

Keyphrases

placebo controlled
papillary thyroid
advanced cancer
double blind
squamous cell
locally advanced
clinical trial
palliative care
squamous cell carcinoma
young adults
physical activity
depressive symptoms
childhood cancer
rectal cancer